Barry Douglas
SEC CIK 1890662 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | GC | 68.6K | — | $51.3K | 5 | 2023-03-01 | 2025-02-04 |
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Beckman Daniella | CFO | — | $126.6K |
| 5 | Ketchum John B | Dir | — | — |
| 6 | Peters Malte | Pres, CEO, Dir | — | — |
| 7 | Rothenberg Mace | Dir | — | — |
| 8 | Gall Matthew | CFO | — | — |
| 9 | Lee Sung | Dir | — | — |
| 10 | Calhoun Lesley Ann | Dir | — | — |
Barry Douglas made no open-market trades at TNGX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | 2025-02-04+ | TNGX | Tango Therapeutics, Inc. | Barry Douglas | GC | S - Sale | $3.07 | -5,330 | 68.6K | -7% | -$16.4K |
| D | 2025-02-05 | 2025-02-03 | TNGX | Tango Therapeutics, Inc. | Barry Douglas | GC | A - Grant | $0.00 | +27.4K | 71.3K | +62% | $0 |
| M | 2024-02-08 | 2024-02-06+ | TNGX | Tango Therapeutics, Inc. | Barry Douglas | GC | S - Sale | $12.59 | -2,776 | 45.3K | -6% | -$34.9K |
| D | 2024-02-05 | 2024-02-01 | TNGX | Tango Therapeutics, Inc. | Barry Douglas | GC | A - Grant | $0.00 | +22.9K | 22.9K | New | $0 |
| D | 2023-03-02 | 2023-03-01 | TNGX | Tango Therapeutics, Inc. | Barry Douglas | GC | A - Grant | $0.00 | +23.9K | 23.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations